Literature DB >> 1731114

Unusual structure of the human immunodeficiency virus type 1 trans-activation response element.

R A Colvin1, M A Garcia-Blanco.   

Abstract

The trans-activation response element (TAR) of human immunodeficiency virus type 1 is a structured RNA consisting of the first 60 nucleotides of all human immunodeficiency virus type 1 RNAs. Computer analyses and limited structural analyses indicated that TAR consists of a stem-bulge-loop structure. Mutational analyses showed that sequences in the bulge are required for Tat binding, whereas sequences in both the bulge and the loop are required for trans activation. In this study, we probed the structures of TAR and various mutants of TAR with chemical probes and RNases and used these methods to footprint a Tat peptide on TAR. Our data show that the structure of wild-type TAR is different from previously published models. The bulge, a Tat-binding site, consists of four nucleotides. The loop is structured, rather than simply single stranded, in a fashion reminiscent of the structures of the tetraloop 5'-UUCG-3' and the GNRA loop (C. Cheong, G. Varani, and I. Tinoco, Jr., Nature [London] 346:680-682, 1990; H.A. Heus and A. Pardi, Science 253:191-193, 1991). RNA footprint data indicate that three bases in the bulge are protected and suggest that a conformational change occurs upon Tat binding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731114      PMCID: PMC240794     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  FURTHER STUDIES ON THE ALKYLATION OF NUCLEIC ACIDS AND THEIR CONSTITUENT NUCLEOTIDES.

Authors:  P D LAWLEY; P BROOKES
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

Authors:  K M Weeks; C Ampe; S C Schultz; T A Steitz; D M Crothers
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

Review 3.  Mammalian subtilisins: the long-sought dibasic processing endoproteases.

Authors:  P J Barr
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

4.  Trans-activation by HIV-1 Tat via a heterologous RNA binding protein.

Authors:  M J Selby; B M Peterlin
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

5.  Solution structure of an unusually stable RNA hairpin, 5'GGAC(UUCG)GUCC.

Authors:  C Cheong; G Varani; I Tinoco
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

6.  Structural features that give rise to the unusual stability of RNA hairpins containing GNRA loops.

Authors:  H A Heus; A Pardi
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

7.  HIV-1 tat trans-activation requires the loop sequence within tar.

Authors:  S Feng; E C Holland
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

8.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

9.  TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.

Authors:  B Berkhout; A Gatignol; A B Rabson; K T Jeang
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

10.  HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  16 in total

1.  In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.

Authors:  F Ducongé; J J Toulmé
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  Evidence for a base triple in the free HIV-1 TAR RNA.

Authors:  Hendrik Huthoff; Frederic Girard; Sybren S Wijmenga; Ben Berkhout
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

3.  TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation.

Authors:  P R Bohjanen; Y Liu; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

4.  A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.

Authors:  P R Bohjanen; R A Colvin; M Puttaraju; M D Been; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

5.  Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.

Authors:  Y Ben-Asouli; Y Banai; H Hauser; R Kaempfer
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

6.  Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences.

Authors:  M Braddock; P Cannon; M Muckenthaler; A J Kingsman; S M Kingsman
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Design and synthesis of RNA miniduplexes via a synthetic linker approach. 2. Generation of covalently closed, double-stranded cyclic HIV-1 TAR RNA analogs with high Tat-binding affinity.

Authors:  M Y X Ma; K McCallum; S C Climie; R Kuperman; W C Lin; M Sumner-Smith; R W Barnett
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

8.  Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.

Authors:  A Alonso; T P Cujec; B M Peterlin
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.